News | Population Health | January 04, 2017

Smartphone Apps May Help Study Cardiovascular Health, Behaviors

High participation rates help build large data set quickly, but research team reports limitations remain

smartphone apps, cardiovascular health, Stanford University study, patient self-reporting, population health

January 4, 2017 — In a study published online by JAMA Cardiology, researchers from Stanford University assessed the feasibility of measuring physical activity, fitness and sleep from smartphones. The goal was to gain insight into activity patterns associated with life satisfaction and self-reported disease.1

Studies have established the importance of physical activity, fitness, sleep and diet for cardiovascular health, yet these studies were completed with time-consuming, in-person measurements with substantial reliance on participant recall. Mobile technology, in particular advances in smartphone sensors, offers a new approach to the study of cardiovascular health and fitness. Direct measurement of activity through always-on, low-power motion chips provides a promising alternative to questionnaire-based approaches.

In 2015, Apple Inc. introduced an open-source framework to facilitate clinical research and standardization of data collection. One of the launch smartphone apps for the framework, MyHeart Counts, is a cardiovascular health study administered entirely via smartphone, incorporating direct sensor-based measurements of physical activity and fitness, as well as questionnaire assessment of sleep, lifestyle factors, risk perception and overall well-being.

From the launch to the time of the data freeze for this study (March to October 2015), the number of individuals (self-selected) who consented to participate was 48,968, representing all 50 states and the District of Columbia. Their median age was 36 years, and 82 percent were male. In total, 40,017 (82 percent of those who consented) uploaded data. Among those who consented, 42 percent completed four of the seven days of motion data collection, and 9 percent completed all seven days. Among those who consented, 82 percent filled out some portion of the questionnaires, and 10 percent completed the six-minute walk test, made available only at the end of seven days.

"Our study found five main results. First, we demonstrate the feasibility of consenting and engaging a large population across the United States using only smartphones. Second, we show that large-scale data can be gathered in real time from mobile devices, stored securely, transferred, deidentified and shared securely, including with participants. Third, we find that a data set for the six-minute walk test larger than any previously collected could be generated in weeks. Fourth, we report that state transition patterns of activity, not just absolute activity, relate to the reported presence of disease. Fifth, we conclude that there is a poor association between perceived and recorded physical activity, as well as perceived and formally estimated risk," the authors wrote.

"Most important, we also present the major challenges and limitations of mobile health research, including the skewed age and sex of participants, plus the rapid drop-off in engagement over time, with the resulting loss of data collection for several measures. To realize the promise of this novel approach to population health research, participant engagement needs to be optimized to maximize full participation of those who have expressed at least enough interest to download the app and consent to join the study."

"Large-scale, real-world assessment of physical activity, fitness and sleep using mobile devices may be a useful addition to future population health studies," the researchers concluded.

Read the article "How Smartphones and Apps May Change the Face of Healthcare."

For more information: www.jamanetwork.com/journals/jamacardiology

References

1. McConnell, M.V., Shcherbina, A., Pavlovic, A., et al. "Feasibility of Obtaining Measures of Lifestyle From a Smartphone App: The MyHeart Counts Cardiovascular Health Study," JAMA Cardiology. Published online Dec. 14, 2016. doi:10.1001/jamacardio.2016.4395

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Clarius Wireless Ultrasound Scanners Now Available With Advanced Features
News | Ultrasound Imaging| August 09, 2017
Clarius Mobile Health has released advanced features and options for its wireless handheld ultrasound scanner for...
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Overlay Init